Fontus Health Limited - Wyniki wyszukiwania

Unia Europejska - polski - EMA (European Medicines Agency)

zulvac 8 bovis

zoetis belgium - inaktywowany wirus choroby niebieskiego języka, serotyp 8, szczep btv-8 / bel2006 / 02 - immunologiczne - bydło - active immunisation of cattle from three months of age for the prevention of viraemia caused by bluetongue virus, serotype 8.

Unia Europejska - polski - EMA (European Medicines Agency)

plavix

sanofi winthrop industrie - wodorosiarczan klopidogrelu - stroke; peripheral vascular diseases; atrial fibrillation; myocardial infarction; acute coronary syndrome - Środki przeciwzakrzepowe - secondary prevention of atherothrombotic eventsclopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;adult patients suffering from acute coronary syndrome:non-st-segment-elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa);st-segment-elevation acute myocardial infarction, in combination with asa in patients undergoing percutaneous coronary intervention (including patients undergoing a stent replacement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. in patients with moderate to high-risk transient ischemic attack (tia) or minor ischemic stroke (is)clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. zapobieganie aterotrombotičeskih i zakrzepowo-zatorowych w przypadku migotania fibrillationin dorosłych pacjentów z migotaniem przedsionków, które mają co najmniej jeden czynnik ryzyka występowania naczyniowych zdarzeń, nie nadają się do leczenia witaminy-do-antagonistów i które mają niskie ryzyko krwawienia, klopidogrel jest wskazany w skojarzeniu z asa w celu zapobiegania aterotrombotičeskih i zakrzepowo-zatorowych, w tym udaru mózgu.

Unia Europejska - polski - EMA (European Medicines Agency)

bylvay

albireo - odevixibat - cholestasis, intrahepatic - terapia żółci i wątroby - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 i 5.

Unia Europejska - polski - EMA (European Medicines Agency)

abrysvo

pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - infekcje wirusem oddechowym - szczepionki - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. zobacz rozdziały 4. 2 i 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. stosowanie tej szczepionki powinno odbywać się zgodnie z oficjalnymi zaleceniami.